Table 1.

Patient demographics and disease characteristics at baseline

Total
Characteristic(N = 52)
Age, y
 Median59.5
 Min, max38.0, 78.0
 ≤65 y, n (%)36 (69.2)
Gender, n (%)
 Male31 (59.6)
 Female21 (40.4)
Race, n (%)
 White45 (86.5)
 Black/African American4 (7.7)
 Asian2 (3.8)
 Native Hawaiian/Other Pacific Islander1 (1.9)
ECOG status, n (%)
 020 (38.5)
 131 (59.6)
 21 (1.9)
Tumor site, n (%)
 Colorectal29 (55.8)
 Melanoma6 (11.5)
 Renal cell carcinoma3 (5.8)
 Other14 (26.9)
Locally advanced disease, n (%)
 Yes33 (63.5)
 No19 (36.5)
Locations of metastatic disease, n (%)
 Lung38 (73.1)
 Liver30 (57.7)
 Lymph nodes27 (51.9)
 Bone6 (11.5)
 Ascites3 (5.8)
 Skin or subcutaneous tissue2 (3.8)
 Pancreas1 (1.9)
 Pleural effusion1 (1.9)
 Othera22 (42.3)
  • Abbreviation: ECOG, Eastern Cooperative Oncology Group.

  • aIncludes lesions detected in or invading the spleen, adrenals, abdominal wall, ovary, peritoneum, kidney, small bowel, mesentery, bladder, chest wall, mediastinum, pleura, pelvis, uterus, and ureters.